Eovist

Active Ingredient(s): Gadoxetate Disodium
FDA Approved: * July 3, 2008
Pharm Company: * BAYER HLTHCARE
Category: Diagnostic Aid

Gadoxetic acid is a gadolinium-based MRI contrast agent. Its salt, gadoxetate disodium, is marketed as Primovist in Europe and Eovist in the United States by Bayer HealthCare Pharmaceuticals.[1][3] See also Gadobenic acid Gadopentetic acid References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-col... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Eovist 181.43 mg/ml Intravenous Injection, Solution
NDC: 50419-320
Labeler:
Bayer Healthcare Pharmaceuticals Inc.

Popular Topics

EOvist in renally impaired patients

Since 50% of the excretion is by the liver - I would think this is the ideal contrast for any patient with renal comprom...